Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 1, 1999, Pages 172-174

  Gangneux, Jean Pierre ^a   Dullin, Michael ^a   Sulahian, Annie ^a   Garin, Yves Jean Francois ^a   Derouin, Francis ^a  

^a Lab de Parasitologie Mycologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MEGLUMINE ANTIMONATE; METRONIDAZOLE; TERBINAFINE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG EFFICACY; LEISHMANIA INFANTUM; LEISHMANIASIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0345561558     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.1.172     Document Type: Article

References (31)

1. Alvar, J., C. Canavate, B. Gutierrez-Solar, M. Jimenez, F. Laguna, R, Lopez-Velez, R. Molina, and J. Moreno. 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 10:298-319.
2. Arranz-Caso, J. A., F. Albarran-Hernandez, L. M. Cuadrado-Gomez, and R. Gonzalez-Palacios. 1995. Metronidazole treatment in a patient with AIDS and visceral leishmaniasis. AIDS 9:1377-1378.
3. Baillie, A. J., T. F. Dolan, J. Alexander, and K. C. Carter. 1989. Visceral leishmaniasis in the Balb/c mouse: sodium stibogluconate treatment during acute and chronic stages of infection. Int. J. Pharm. 57:23-28.
4. Baum, K. F., and R. L. Berens. 1994. Successful treatment of cutaneous leishmaniasis with allopurinol after failure of treatment with ketoconazole. Clin. Infect. Dis. 18:813-815.
5. Berman, J. D. 1997. Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24:684-703.
6. Buffet, P. A., A. Sulahian, Y. J. F. Garin, N. Nassar, and F. Derouin. 1995. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob. Agents Chemother. 39:2167-2168.
7. Carter, K. C., T. F. Dolan, J. Alexander, A. J. Baillie, and C. McColgan. 1989. Visceral leishmaniasis: drug carrier system characteristics and the ability to clear parasites from the liver, spleen and bone marrow in Leishmania donovani infected Balb/c mice. J. Pharm. Pharmacol. 41:87-91.
8. Collins, M., K. C. Carter, and A. J. Baillie. 1992. Visceral leishmaniasis in the Balb/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconate. Ann. Trop. Med. Parasitol. 86:35-40.
9. Cook, G. C. 1993. Leishmaniasis: some recent developments in chemotherapy. J. Antimicrob. Chemother. 31:327-330.
10. Dan, M., E. Verner, J. El-On, F. Zuckerman, and D. Michaeli. 1986. Failure of oral ketoconazole to cure cutaneous ulcers caused by Leishmania braziliensis. Cutis 38:198-199.
11. Dedet, J. P., P. Jamet, P. Esterre, P. M. Ghipponi, C. Genin, and G. Lalande. 1986. Failure to cure Leishmania braziliensis guyanensis cutaneous leishmaniasis with oral ketokonazole. Trans. R. Soc. Trop. Med. Hyg. 80:296.
12. Dogra, J., and V. N. Saxena. 1996. Itraconazole and leishmaniasis: a randomised double-blind trial in cutaneous disease. Int. J. Parasitol. 26:1413-1415.
13. Gangneux, J. P., A. Sulahian, Y. J. F. Garin, and F. Derouin. 1997. Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum. J. Antimicrob. Chemother. 40:287-289.
14. Gangneux, J. P., A. Sulahian, Y. J. F. Garin, and F. Derouin. 1996. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of the efficacy of AmBisome. Antimicrob. Agents Chemother. 40:1214-1218.
15. Gangneux, J. P., A. Sulahian, Y. J. F. Garin, and F. Derouin. 1996. Lipid formulations of amphotericin B in the treatment of experimental visceral leishmaniasis due to Leishmania infantum. Trans. R. Soc. Trop. Med. Hyg. 90:574-577.
16. Gradoni, L., A. Bryceson, and P. Desjeux. 1995. Treatment of Mediterranean visceral leishmaniasis. Bull. W. H. O. 73:191-197.
17. Halim, M. A., O. Alfurayh, M. E. Kalin, S. Dammas, A. Al-Eisa, and G. Damanhouri. 1993. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate. Clin. Infect. Dis. 16:397-399.
18. Jollife, D. S. 1986. Cutaneous leishmaniasis from Belize - treatment with ketoconazole. Clin. Exp. Dermatol. 11:62-68.
19. Keithly, J. S., and S. G. Langreth. 1983. Inefficacy of metronidazole in experimental infections of Leishmania donovani, L. mexicana and Trypanosoma brucei brucei. Am. J. Trop. Med. Hyg. 32:485-496.
20. Khalil, E. A. G., N. M. Nur, E. E. Zijlstra, A. M. El Hassan, and R. N. Davidson. 1996. Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post-kala-azar dermal leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 90:187-188.
21. Lafeuillade, A., P. Chaffanjon, E. Delbeke, and R. Quilichi. 1992. Maintenance itraconazole for visceral leishmaniasis in HIV infection. Am. J. Med. 92:449.
22. Laguna del Estral, P., M. S. Moya, T. Martin, M. J. Lacera, and R. Salgado. 1994. Metronidazole therapy for visceral leishmaniasis. Clin. Infect. Dis. 19:1161-1162.
23. Mbongo, N., P. M. Loiseau, M. A. Billion, and M. Robert-Gero. 1998. Mechanism of amphotericin B resistance in Leishmania donovani promastigotes. Antimicrob. Agents Chemother. 42:352-357.
24. Mishra, M., B. D. Thakur, and M. Choudhary. 1985. Metronidazole and Indian kala-azar: results of a clinical trial. Br. Med. J. Clin. Res. Ed. 291: 1611.
25. Navin, T. R., A. B. A. Arana, F. E. Arana, J. D. Berman, and J. F. Chajon. 1992. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J. Infect. Dis. 165:528-534.
26. Raffi, F., D. Merrien, P. Le Pape, and V. Reliquet. 1995. Use of itraconazole/ allopurinol combination for the treatment of visceral leishmaniasis in a patient with AIDS. Clin. Infect. Dis. 21:1338-1339.
27. Saenz, R. E., and H. Paz. 1990. Efficacy of ketoconazole against Leishmania braziliensis cutaneous leishmaniasis. Am. J. Med. 89:147-155.
28. Thakur, C. P., and P. K. Sinha. 1989. Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar. Am. J. Trop. Med. Hyg. 92:383-385.
29. Torrus, D., V. Boix, B. Massa, J. Portilla, and M. Perez-Mateo. 1996. Fluconazole plus allopurinol in the treatment of visceral leishmaniasis. J. Antimicrob. Chemother. 37:1042-1043.
30. Wall, J. P., P. Aggarwal, U. Gupta, S. Saluja, and S. Singh. 1992. Ketoconazole in the treatment of antimony-and pentamidine-resistant kala-azar. J. Infect. Dis. 166:215-216.
31. Weinrauch, L., R. Livishin, and J. El-On. 1987. Ketoconazole in cutaneous leishmaniasis. Br. J. Dermatol. 117:666-667.